The Discounted Cash Flow (DCF) valuation of Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) is (202.67) INR. With the latest stock price at 86.00 INR, the upside of Krebs Biochemicals and Industries Ltd based on DCF is -335.7%.
Based on the latest price of 86.00 INR and our DCF valuation, Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) is a sell. selling KREBSBIO.NS stocks now will result in a potential gain of 335.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 8.5% - 12.4% | 10.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (280.50) - (173.44) | (202.67) |
| Upside | -426.2% - -301.7% | -335.7% |